Landos Biopharma's activity chart (see below) currently has 17 price targets and 17 ratings on display.
Analysts' price targets on this stock were met 12.5% of the time, taking 129.5 days on average.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2024. First documented stock forecast 01-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2021
$20.42
$500
2 years 7 months 21 days ago
(01-Apr-2024)
0/2 (0%)
$-1.18 (-5.46%)
Hold Since 06-Jan-2023
$1
$14
3 years 10 months 16 days ago
(06-Jan-2023)
1/4 (25%)
$-3.05 (-75.31%)
713
Hold Since 12-Aug-2022
4 years 11 days ago
(11-Nov-2022)
0/2 (0%)
$53.4 (50.09%)
Buy Since 01-Mar-2021
$60
$90
4 years 3 months 10 days ago
(12-Aug-2022)
0/3 (0%)
$49.4 (466.04%)
Hold Since 01-Mar-2021
$70
$170
4 years 10 months 19 days ago
(03-Jan-2022)
0/2 (0%)
$17.8 (34.10%)
What is LABP (Landos Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on LABP (Landos Biopharma)?
Which analyst has the lowest performance score on LABP (Landos Biopharma) with a proven track record?
Which analyst has the most public recommendations on LABP (Landos Biopharma)?
Which analyst is the currently most bullish on LABP (Landos Biopharma)?
Which analyst is the currently most reserved on LABP (Landos Biopharma)?